Matinas Biopharma (MTNB) Stock Chart & Stock Price History $1.76 -0.15 (-7.63%) As of 10:01 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartHeadlinesOwnershipSEC FilingsShort InterestBuy This Stock Matinas Biopharma Stock Price Performance The Matinas Biopharma (MTNB) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock increased 244.12%. In the past month, the stock has increased 6.36%, reflecting recent market activity. As of the latest close, Matinas Biopharma traded at $1.71 with a market cap of $8.70 million and volume of 24,296 shares. Five years ago, the stock traded at $0.89, representing a 96.44% increase over that period. At the time, it had a market cap of $177.74 million and a volume of 1.43 million shares. Receive MTNB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Matinas Biopharma and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+2.63%1 Month Performance+6.36%3 Month Performance+82.81%Year-To-Date Performance+244.12%5 Year Performance+96.44% MTNB Stock Chart for Friday, October, 17, 2025 MTNB Chart by TradingView Matinas Biopharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/16/2025$1.90$1.71-10.00%$1.89$1.7124,296 shs$8.70 million10/15/2025$1.90$1.90$1.93$1.8055,006 shs$9.67 million10/14/2025$1.84$1.90+3.54%$1.90$1.7529,101 shs$9.67 million10/13/2025$1.71$1.84+7.31%$1.87$1.7539,574 shs$9.34 million10/10/2025$1.86$1.71-8.06%$1.85$1.7179,606 shs$8.70 million10/09/2025$1.87$1.86-0.53%$1.91$1.8333,060 shs$9.47 million10/08/2025$1.89$1.87-1.06%$1.93$1.8239,640 shs$9.52 million10/07/2025$1.90$1.89-0.63%$1.96$1.8444,563 shs$9.62 million10/06/2025$1.94$1.90-1.96%$1.97$1.8372,772 shs$9.68 million10/03/2025$1.93$1.94+0.52%$1.95$1.8853,450 shs$9.87 million Get the Latest News and Ratings for MTNB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Matinas Biopharma and its competitors with MarketBeat's FREE daily newsletter. 10/02/2025$1.87$1.93+3.49%$1.93$1.8728,300 shs$9.82 million10/01/2025$1.90$1.87-1.58%$1.92$1.8325,428 shs$9.49 million09/30/2025$1.90$1.90-0.26%$1.99$1.8535,183 shs$9.64 million09/29/2025$1.90$1.90$1.91$1.8319,989 shs$9.67 million09/26/2025$1.88$1.90+1.06%$1.98$1.8526,228 shs$9.67 million09/25/2025$1.92$1.88-2.08%$1.99$1.87266,647 shs$9.56 million09/24/2025$1.94$1.92-1.03%$2.02$1.8855,867 shs$9.77 million09/23/2025$2.06$1.94-5.83%$2.07$1.9341,033 shs$9.87 million09/22/2025$1.75$2.06+17.71%$2.14$1.72126,697 shs$10.48 million09/19/2025$1.73$1.75+1.16%$1.85$1.7122,297 shs$8.90 million09/18/2025$1.65$1.73+4.85%$1.73$1.6511,252 shs$8.80 million09/17/2025$1.70$1.65-2.94%$1.77$1.6568,790 shs$8.39 million09/16/2025$1.75$1.70-2.86%$1.80$1.6948,801 shs$8.65 million Related Companies MURA Stock Price Chart MAAQ Stock Price Chart ITRM Stock Price Chart XFOR Stock Price Chart TENX Stock Price Chart RANI Stock Price Chart SCYX Stock Price Chart ANVS Stock Price Chart XCUR Stock Price Chart TAOX Stock Price Chart Receive MTNB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Matinas Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEAMERICAN:MTNB) was last updated on 10/17/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored7 market signals flashing red right nowRight now, the same 7 key indicators that predicted 1929, the 1970s stagflation, and the 2008 meltdown are all...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Matinas Biopharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Matinas Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
